ES355054A1 - Procedimiento de fabricacion de comprimidos de elementos concentricos. - Google Patents
Procedimiento de fabricacion de comprimidos de elementos concentricos.Info
- Publication number
- ES355054A1 ES355054A1 ES355054A ES355054A ES355054A1 ES 355054 A1 ES355054 A1 ES 355054A1 ES 355054 A ES355054 A ES 355054A ES 355054 A ES355054 A ES 355054A ES 355054 A1 ES355054 A1 ES 355054A1
- Authority
- ES
- Spain
- Prior art keywords
- nucleus
- ingredient
- retarding
- active ingredient
- outer layers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 6
- 239000004615 ingredient Substances 0.000 abstract 5
- 230000000979 retarding effect Effects 0.000 abstract 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 abstract 2
- ZMSQJSMSLXVTKN-UHFFFAOYSA-N 4-[2-(2-morpholin-4-ylethoxy)ethyl]morpholine Chemical compound C1COCCN1CCOCCN1CCOCC1 ZMSQJSMSLXVTKN-UHFFFAOYSA-N 0.000 abstract 1
- FPEWXTXBURZCKT-VVSTWUKXSA-N 5,7-dihydroxy-2-[3-hydroxy-4-(2-morpholin-4-ylethoxy)phenyl]-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(OCCN3CCOCC3)=CC=2)=O)O1 FPEWXTXBURZCKT-VVSTWUKXSA-N 0.000 abstract 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 abstract 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 235000021355 Stearic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 235000013869 carnauba wax Nutrition 0.000 abstract 1
- 239000004203 carnauba wax Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 abstract 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
- 229960001789 papaverine Drugs 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 abstract 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 abstract 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 abstract 1
- 235000005493 rutin Nutrition 0.000 abstract 1
- 229960004555 rutoside Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000008117 stearic acid Substances 0.000 abstract 1
- 238000009495 sugar coating Methods 0.000 abstract 1
- 229940045860 white wax Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B41/00—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone
- C04B41/45—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements
- C04B41/50—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials
- C04B41/5025—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials with ceramic materials
- C04B41/5042—Zirconium oxides or zirconates; Hafnium oxides or hafnates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ceramic Engineering (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Structural Engineering (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR110534A FR1545612A (fr) | 1967-06-15 | 1967-06-15 | Procédé de fabrication de comprimés |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES355054A1 true ES355054A1 (es) | 1969-11-16 |
Family
ID=8633106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES355054A Expired ES355054A1 (es) | 1967-06-15 | 1968-06-15 | Procedimiento de fabricacion de comprimidos de elementos concentricos. |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE716530A (enrdf_load_stackoverflow) |
| DE (1) | DE1767765A1 (enrdf_load_stackoverflow) |
| ES (1) | ES355054A1 (enrdf_load_stackoverflow) |
| FR (1) | FR1545612A (enrdf_load_stackoverflow) |
| GB (1) | GB1233055A (enrdf_load_stackoverflow) |
| IL (1) | IL30165A (enrdf_load_stackoverflow) |
| IT (1) | IT954035B (enrdf_load_stackoverflow) |
| LU (1) | LU56264A1 (enrdf_load_stackoverflow) |
| NL (1) | NL151902B (enrdf_load_stackoverflow) |
| SU (1) | SU458966A3 (enrdf_load_stackoverflow) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5138412A (en) * | 1974-09-24 | 1976-03-31 | Nippon Kayaku Kk | Kokoseizai no seiho |
| US4076804A (en) * | 1975-07-18 | 1978-02-28 | Abbott Laboratories | Erythromycin therapy |
| SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
| US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
| US4503031A (en) * | 1982-12-17 | 1985-03-05 | Glassman Jacob A | Super-fast-starting-sustained release tablet |
| DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
| US5032406A (en) * | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
| US5213807A (en) * | 1990-05-03 | 1993-05-25 | Chemburkar Pramod B | Pharmaceutical composition containing ibuprofen and a prostaglandin |
| EP1836665B1 (en) | 2004-11-19 | 2013-01-16 | GlaxoSmithKline LLC | Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
-
1967
- 1967-06-15 FR FR110534A patent/FR1545612A/fr not_active Expired
-
1968
- 1968-06-12 IL IL30165A patent/IL30165A/en unknown
- 1968-06-13 LU LU56264A patent/LU56264A1/xx unknown
- 1968-06-13 NL NL686808312A patent/NL151902B/xx unknown
- 1968-06-13 BE BE716530D patent/BE716530A/xx unknown
- 1968-06-14 GB GB1233055D patent/GB1233055A/en not_active Expired
- 1968-06-14 DE DE19681767765 patent/DE1767765A1/de active Pending
- 1968-06-14 IT IT52034/68A patent/IT954035B/it active
- 1968-06-14 SU SU1247008A patent/SU458966A3/ru active
- 1968-06-15 ES ES355054A patent/ES355054A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE1767765A1 (de) | 1972-03-30 |
| LU56264A1 (enrdf_load_stackoverflow) | 1968-09-23 |
| NL151902B (nl) | 1977-01-17 |
| IT954035B (it) | 1973-08-30 |
| NL6808312A (enrdf_load_stackoverflow) | 1968-12-16 |
| IL30165A0 (en) | 1968-08-22 |
| FR1545612A (fr) | 1968-11-15 |
| SU458966A3 (ru) | 1975-01-30 |
| IL30165A (en) | 1973-04-30 |
| GB1233055A (enrdf_load_stackoverflow) | 1971-05-26 |
| BE716530A (enrdf_load_stackoverflow) | 1968-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES355054A1 (es) | Procedimiento de fabricacion de comprimidos de elementos concentricos. | |
| JPS5620513A (en) | Sugar-coated tablet containing fat-soluble drug | |
| CA933406A (en) | Method of incorporating photographic ingredients into photographic colloid compositions | |
| IE34623L (en) | Nitrofuryl-pyrazolopyrimidinones | |
| IL30329A0 (en) | New 13beta-alkyl-9beta,10alpha-pregnanes,methods of producing the same,pharmaceutical compositions comprising the new compounds as an active ingredient and a method of producing these compositions | |
| IL30181A (en) | 1-(substituted phenoxy)-2-hydroxy-3-tertiary butylaminopropanes,their preparation and pharmaceutical compositions containing them | |
| GB1147245A (en) | Method for the production of slow release pharmaceutical compositions | |
| IL30856A0 (en) | New phenanthridine derivatives,processes for their preparation and pharmaceutical compositions containing them | |
| CA763864A (en) | Spray forming breathable layer of normally solid polymer | |
| IL33942A0 (en) | Triazole derivatives,their preparation and pharmaceutical compositions containing them | |
| ZA704380B (en) | 17b-hydroxy-17alpha-(2-methallyl)9beta,10alpha-androsta-1,4,6-trien-3-one,methods of producing this compound and pharmaceutical compositions comprising said compound as an active ingredient | |
| CA768658A (en) | Method for preparation of 2,2'-thiobis (6-cumyl-p-cresol) | |
| AU440336B2 (en) | Derivatives of dialkylcysteines, and related compounds, preparation thereof, and compositions containing same | |
| SE386181B (sv) | Forfarande for framstellning av 6-(d-(-)-2,2-dimetyl-4-(3-klor-4-hydroxifenyl)-5-oxo-1-imidazolidinyl)penicillansyra och ogiftiga, farmaceutisktgodtagbara salter derav. | |
| AU430222B2 (en) | Soluble derivatives of benzimidazoles for use as fungicides | |
| AU419479B2 (en) | Pharmaceutical compositions comprising alkaloids | |
| AU1933767A (en) | Coating compositions and processes for preparing same | |
| CA764943A (en) | Methods and fungicidal compositions for the control of vascular fungus disease of trees | |
| CA723658A (en) | Derivatives of substituted coumarin, compositions containing them and their preparation | |
| CA763458A (en) | Preparation of halophosphorous compositions | |
| AU415310B2 (en) | Azaspiroalkanediones, process for preparing thesame and pharmaceutical compositions comprising thesame | |
| CA749983A (en) | Pharmaceutical compositions comprising an arganine compound | |
| AU2364267A (en) | Soluble derivatives of benzimidazoles for use as fungicides | |
| CA855929A (en) | Containerized tree seedling units and method of making these units | |
| AU3153767A (en) | Pharmaceutical compositions comprising alkaloids |